Home/Filings/4/0001209191-23-045412
4//SEC Filing

Azelby Robert 4

Accession 0001209191-23-045412

CIK 0001435049other

Filed

Aug 10, 8:00 PM ET

Accepted

Aug 11, 4:04 PM ET

Size

9.9 KB

Accession

0001209191-23-045412

Insider Transaction Report

Form 4
Period: 2023-08-11
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2023-08-11$18.40/sh28,200$518,8800 total
    Exercise: $21.60Exp: 2033-04-09Common Stock (28,200 underlying)
  • Disposition to Issuer

    Restricted Stock Units

    2023-08-117,0000 total
    Common Stock (7,000 underlying)
Footnotes (3)
  • [F1]This stock option award, which provided for ratable vesting in 36 monthly installments beginning on May 10, 2023, became fully vested and was canceled upon effectiveness of the Merger (defined in the Remarks below), and was converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such option, (i) a cash payment representing the excess, if any, of the per share merger consideration ($40.00 per share) over the per share exercise price for such option, without interest, and (ii) one contingent value right ("CVR"), entitling the reporting person to additional cash payments upon the achievement of certain future business milestones pursuant to the contingent value rights agreement entered into concurrent with the completion of the Merger, in each case subject to applicable withholding taxes.
  • [F2]When granted, each restricted stock unit ("RSU") represented a contingent right to receive one share of the Issuer's Common Stock upon settlement.
  • [F3]When granted, the RSU award provided for ratable vesting in annual installments of one-third beginning on April 10, 2024. Pursuant to the Merger Agreement (defined in the Remarks below), at the effective time of the Merger, the RSU award was cancelled and converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such RSU, (i) a cash payment equal to $40.00 (without interest and subject to any applicable tax withholding), and (ii) one CVR.

Issuer

CHINOOK THERAPEUTICS, INC.

CIK 0001435049

Entity typeother

Related Parties

1
  • filerCIK 0001656998

Filing Metadata

Form type
4
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 4:04 PM ET
Size
9.9 KB